BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28238344)

  • 1. Implications of inaccurate clinical nodal staging in pancreatic adenocarcinoma.
    Swords DS; Firpo MA; Johnson KM; Boucher KM; Scaife CL; Mulvihill SJ
    Surgery; 2017 Jul; 162(1):104-111. PubMed ID: 28238344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External radiation is associated with limited improvement in overall survival in resected margin-negative stage IIB pancreatic adenocarcinoma.
    Kantor O; Talamonti MS; Lutfi W; Wang CH; Winchester DJ; Marsh R; Prinz RA; Baker MS
    Surgery; 2016 Dec; 160(6):1466-1476. PubMed ID: 27614417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the 8th AJCC staging system for pathologically versus clinically staged pancreatic adenocarcinoma: A time to revisit a dogma?
    Abdel-Rahman O
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):64-69. PubMed ID: 29428107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
    Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
    World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant therapy versus upfront surgery for resected pancreatic adenocarcinoma: A nationwide propensity score matched analysis.
    de Geus SW; Eskander MF; Bliss LA; Kasumova GG; Ng SC; Callery MP; Tseng JF
    Surgery; 2017 Mar; 161(3):592-601. PubMed ID: 28341441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AJCC 8th edition pathologic nodal staging of resected pancreatic adenocarcinoma predicts survival regardless of treatment sequencing.
    Oppliger FA; Prakash LR; Newhook TE; Chiang YJ; Ikoma N; Maxwell JE; Kim MP; Vauthey JN; Lee JE; Katz MH; Tzeng CD
    Surg Oncol; 2022 Mar; 40():101673. PubMed ID: 34894620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of lymph node positivity in treatment planning for early stage pancreatic cancer.
    Tran Cao HS; Zhang Q; Sada YH; Silberfein EJ; Hsu C; Van Buren G; Chai C; Katz MHG; Fisher WE; Massarweh NN
    Surgery; 2017 Sep; 162(3):557-567. PubMed ID: 28666686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Underuse of surgical resection among elderly patients with early-stage pancreatic cancer.
    He W; Zhao H; Chan W; Lopez D; Shroff RT; Giordano SH
    Surgery; 2015 Nov; 158(5):1226-34. PubMed ID: 26138347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis.
    Slidell MB; Chang DC; Cameron JL; Wolfgang C; Herman JM; Schulick RD; Choti MA; Pawlik TM
    Ann Surg Oncol; 2008 Jan; 15(1):165-74. PubMed ID: 17896141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overall survival is increased among stage III pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy compared to surgery first and adjuvant chemotherapy: An intention to treat analysis of the National Cancer Database.
    Shubert CR; Bergquist JR; Groeschl RT; Habermann EB; Wilson PM; Truty MJ; Smoot RL; Kendrick ML; Nagorney DM; Farnell MB
    Surgery; 2016 Oct; 160(4):1080-1096. PubMed ID: 27522556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the American Joint Commission on Cancer (AJCC) 8th Edition Staging System for Patients with Pancreatic Adenocarcinoma: A Surveillance, Epidemiology and End Results (SEER) Analysis.
    Kamarajah SK; Burns WR; Frankel TL; Cho CS; Nathan H
    Ann Surg Oncol; 2017 Jul; 24(7):2023-2030. PubMed ID: 28213792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database.
    Bilimoria KY; Bentrem DJ; Ko CY; Ritchey J; Stewart AK; Winchester DP; Talamonti MS
    Cancer; 2007 Aug; 110(4):738-44. PubMed ID: 17580363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors.
    Cleary SP; Gryfe R; Guindi M; Greig P; Smith L; Mackenzie R; Strasberg S; Hanna S; Taylor B; Langer B; Gallinger S
    J Am Coll Surg; 2004 May; 198(5):722-31. PubMed ID: 15110805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant radiation followed by resection versus upfront resection for locally advanced pancreatic cancer patients: a propensity score matched analysis.
    Chen X; Liu G; Wang K; Chen G; Sun J
    Oncotarget; 2017 Jul; 8(29):47831-47840. PubMed ID: 28599299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel scoring system predicts postsurgical survival and adjuvant chemotherapeutic benefits in patients with pancreatic adenocarcinoma: Implications for AJCC-TNM staging.
    Liu L; Xu HX; He M; Wang W; Wang WQ; Wu CT; Wei RQ; Liang Y; Gao HL; Liu C; Xu J; Long J; Ni QX; Shao CH; Wang J; Yu XJ
    Surgery; 2018 Jun; 163(6):1280-1294. PubMed ID: 29548773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative mortality following multi-modality therapy for pancreatic cancer: Analysis of the SEER-Medicare data.
    Nayar P; Chandak A; Gupta N; Yu F; Qiu F; Ganti AK; Are C
    J Surg Oncol; 2017 Feb; 115(2):158-163. PubMed ID: 28133817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-based outcome of stage IA-IIA resected gastric adenocarcinoma: who should get adjuvant treatment?
    Gold JS; Al Natour RH; Saund MS; Yoon C; Sharma AM; Huang Q; Boosalis VA; Whang EE
    Ann Surg Oncol; 2013 Jul; 20(7):2304-10. PubMed ID: 23344580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A matched-cohort analysis of 192 pancreatic anaplastic carcinomas and 960 pancreatic adenocarcinomas: A 13-year North American experience using the National Cancer Data Base (NCDB).
    Paniccia A; Hosokawa PW; Schulick RD; Henderson W; Kaplan J; Gajdos C
    Surgery; 2016 Aug; 160(2):281-92. PubMed ID: 27085687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Borderline resectable/locally advanced pancreatic adenocarcinoma: improvements needed in population-based registries.
    Miura JT; Evans DB; Pappas SG; Gamblin TC; Turaga KK
    Ann Surg Oncol; 2013 Dec; 20(13):4338-47. PubMed ID: 24002538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative analysis of survival outcomes between pancreatectomy and chemotherapy for elderly patients with adenocarcinoma of the pancreas.
    Marmor S; Burke EE; Virnig BA; Jensen EH; Tuttle TM
    Cancer; 2016 Nov; 122(21):3378-3385. PubMed ID: 27419382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.